Investment Bank Upgrades Invitrogen Stock; Shares Climb 3.6 Percent

Jun 09, 2006

NEW YORK, June 9 (GenomeWeb News) - Invitrogen's shares were up 3.6 percent, or $2.29, at $65.37 in mid-afternoon trading after Bears Sterns upgraded the company's stock to "Outperform" from "Peer Perform" today.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Mysterious Third Group

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

This Week in Science

In Science this week: reduction in bee phylogenetic diversity, and more.

In the Past

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

New Bases, New Drugs

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.

Main menu